What is the history of present illness (HPI), assessment, and management plan for a 60-year-old man with stable exertional angina, hypertension, hyperlipidemia, and a 20-pack-year smoking history?

Angina: History of Present Illness, Assessment, and Management Plan

History of Present Illness (HPI)

Document angina using a chronological, structured approach that captures the essential diagnostic elements. 1, 2

Key Elements to Obtain:

Symptom Characteristics:

• Quality: Pressure, tightness, heaviness, strangling, constricting, or burning (not sharp or stabbing) 3, 1
• Location: Substernal, radiating to jaw, neck, shoulder, arms, or epigastrium 2, 4
• Duration: Brief episodes lasting 2-10 minutes (not seconds, not hours) 3, 1
• Triggers: Exertion, emotional stress, cold weather, heavy meals, morning hours 3, 1
• Relief: Rest within 1-5 minutes, sublingual nitroglycerin within 30 seconds to several minutes 2, 5

Anginal Pattern Classification:

• Stable: Predictable with exertion, unchanged pattern
• Unstable: New onset, increasing frequency/severity, or occurring at rest (requires emergency evaluation) 2

Anginal Equivalents (especially in elderly and women):

• Isolated exertional dyspnea (most common)
• Jaw, neck, or epigastric discomfort alone
• Unexplained fatigue, nausea, diaphoresis 6, 4

Risk Factors (document presence/absence):

1. Age (male >55, female >65 years)
2. Smoking (quantify pack-years: 20 in this case)
3. Hypertension (present)
4. Hyperlipidemia (present)
5. Diabetes mellitus
6. Family history of premature CAD (male <55, female <65 years)
7. Prior MI or known CAD 6, 4

Comorbidities affecting management:

• Heart failure, valvular disease, renal disease, COPD, peripheral arterial disease 1, 5

Assessment

Grade angina severity using Canadian Cardiovascular Society (CCS) Classification: 1, 5

• Class I: Angina only with strenuous exertion
• Class II: Slight limitation; angina with moderate exertion (walking >2 blocks, climbing >1 flight of stairs)
• Class III: Marked limitation; angina with mild exertion (walking 1-2 blocks)
• Class IV: Angina at rest

Physical Examination Priorities:

• Blood pressure measurement (assess hypertension control)
• Heart sounds (S3/S4 during ischemia, murmurs suggesting valvular disease)
• Signs of heart failure (elevated JVP, pulmonary rales, peripheral edema)
• Peripheral pulses and bruits (assess for systemic atherosclerosis)
• Chest wall tenderness (makes angina less likely but doesn't exclude it) 2, 5

Initial Diagnostic Testing:

• Resting ECG (mandatory in all patients) 2
• Lipid panel, fasting glucose/HbA1c, creatinine 7, 1
• Stress testing (exercise ECG or imaging) for diagnosis confirmation and risk stratification 3, 1

Management Plan

Pillar 1: Medications to Prevent MI and Death (Mandatory for All)

Start these immediately regardless of symptom severity: 7, 2

1. Aspirin 75-81 mg daily (or clopidogrel if aspirin contraindicated) 7, 3

2. High-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) 7, 2

3. ACE inhibitor (especially with hypertension, diabetes, LV dysfunction, or high-risk features) 7, 8

4. Beta-blocker (particularly if prior MI or reduced ejection fraction; target resting heart rate 55-60 bpm) 7, 8

Pillar 2: Antianginal Therapy for Symptom Control

First-line approach: 7, 8

1. Sublingual nitroglycerin 0.4 mg (for immediate symptom relief; educate on use) 7

2. Beta-blocker (if not already prescribed for prognostic benefit):

   • Metoprolol succinate 50-200 mg daily OR
   • Carvedilol 12.5-50 mg twice daily
   • Titrate to heart rate 55-60 bpm 7, 8

If beta-blocker contraindicated or not tolerated: 7, 3

• Long-acting calcium channel blocker:
  • Amlodipine 5-10 mg daily OR
  • Diltiazem extended-release 180-360 mg daily
  • Avoid non-dihydropyridines with beta-blockers (risk of heart block/bradycardia) 8

If symptoms persist on monotherapy: 7, 3

• Add long-acting nitrate (isosorbide mononitrate 30-120 mg daily with nitrate-free interval) OR
• Add long-acting calcium channel blocker to beta-blocker 7

Avoid these therapies (no proven benefit):

• Dipyridamole, chelation therapy, testosterone, coenzyme Q10 7, 8

Pillar 3: Aggressive Risk Factor Modification

1. Smoking cessation (critical with 20 pack-year history) 3, 2
2. Blood pressure target <130/80 mmHg 2
3. LDL cholesterol <70 mg/dL (consider <55 mg/dL if very high risk) 7
4. Weight management and regular exercise 8
5. Diabetes control if present (HbA1c <7%) 8

Follow-up and Revascularization Considerations

Optimize medical therapy over 12-16 weeks before considering revascularization (unless high-risk features present). 8

Reassess every 4-6 months in first year, then annually if stable: 7

• Has physical activity decreased?
• Have symptoms worsened despite medication?
• Medication tolerance and adherence?
• Risk factor control achieved?

Consider coronary angiography and revascularization if: 3, 2

• Symptoms remain unacceptable despite optimal medical therapy
• High-risk features on stress testing (extensive ischemia, reduced ejection fraction)
• Left main disease, three-vessel disease, or proximal LAD stenosis with reduced LV function 3

Critical pitfall: Women and elderly patients often present with atypical symptoms (dyspnea, fatigue, epigastric discomfort) rather than classic chest pain—maintain high index of suspicion. 6, 4